openPR Logo
Press release

The Global Multiplex Assay Market Assessed to Reap $7933.87 Million in Revenue by 2028

08-31-2021 02:13 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Triton Market Research

The Global Multiplex Assay Market

The Global Multiplex Assay Market

According to Triton’s report, the global multiplex assay market, which attained $3143.14 million in 2020, is forecasted to register progress at 8.67% of CAGR by 2028.

A recent study by Triton Market Research titled ‘Global Multiplex Assay Market’ comprises the Global Analysis and Forecasts by Product and Service (Software and Services, Reagents and Consumables, Instruments and Accessories), Industry Verticals (Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Laboratories), Application (Companion Diagnostics, Research and Development, Clinical Diagnostics), Technology (Multiplex PCR, Multiplex Protein Microarray, Other Technologies), Type (Nucleic Acid-Based Multiplex Assay, Protein-Based Multiplex Assay, Other Multiplex Assay Types), and by Geography (Europe, North America, Latin America, Middle East and Africa, Asia-Pacific).

Request Free Sample of the Global Multiplex Assay Market Report @ https://www.tritonmarketresearch.com/reports/multiplex-assay-market#request-free-sample

Triton’s report predicts the global multiplex assay market to surge based on revenue at a CAGR of 8.67% during the period 2021-2028. It is further estimated to attain revenue at $7933.87 million by 2028.

Multiplex assays are employed in clinical trials as they can lower research costs, along with increasing the efficiency of therapies.

In recent years, the demand for personalized medicines offering advanced individual treatments has increased globally. In such a scenario, multiple assays have been beneficial to develop these drugs. Thus, the growing use of personalized medicine, in addition to multiplex assays’ use over conventional methods, motivates the development of the multiplex assay market.

On the contrary, the dearth of skilled professionals, along with policies relating to environmental safety, are key factors obstructing the progression of the multiplex assay market.

The market for multiplex assay is divided into product and services, industry verticals, application, technology, and type. The product and service segment comprises software and services, reagents and consumables, and instruments and accessories. Based on industry verticals, the market is divided into research institutes, hospitals, pharmaceutical & biotechnology companies, and clinical laboratories. Furthermore, the application segment is subdivided into companion diagnostics, research and development, and clinical diagnostics. Similarly, the technology section is branched into multiplex PCR, multiplex protein microarray, and other technologies. Lastly, the type segment is segmented into nucleic acid-based multiplex assay, protein-based multiplex assay, and other multiplex assay types.

Geographically, North America is dominating the multiplex assay market. This is mainly owing to the increase in research and development activities to develop novel drugs and treatments. Other than this, the growing prevalence of cancer and other diseases has increased the demand for multiple assays. Above all, the rise in government funding to detect new biomarkers has opened new avenues for the multiplex assay market across North American
nations.

Siemens Healthineers AG, Seegene Inc, Merck Millipore, Bio Techne Corporation, Agilent Technologies Inc, Luminex Corporation, Randox Laboratories Ltd, Illumina Inc, Olink Proteomics AB, F Hoffmann La Roche, Abcam, Meso Scale Diagnostics LLC, Becton Dickinson and Company, Bio Rad Laboratories Inc, Qiagen NV, and Thermo Fisher Scientific Inc are leading organizations in the multiplex assay market.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/multiplex-assay-market#purchase-option

Question & Answer: Multiplex Assay Market

Question 1: What factors motivate the development of the multiplex assay market?

Answer: In recent years, the demand for personalized medicines offering advanced individual treatments has increased globally. In such a scenario, multiple assays have been beneficial to develop these drugs. Thus, the growing use of personalized medicine, in addition to multiplex assays’ use over conventional methods, motivates the development of the multiplex assay market.

Question 2: What key factors are obstructing the progression of the multiplex assay market?

Answer: The dearth of skilled professionals, along with policies relating to environmental safety, are key factors obstructing the progression of the multiplex assay market.

Question 3: Which region is dominating the multiplex assay market?

Answer: Geographically, North America is dominating the multiplex assay market. This is mainly owing to the increase in research and development activities to develop novel drugs and treatments. Other than this, the growing prevalence of cancer and other diseases has increased the demand for multiple assays. Above all, the rise in government funding to detect new biomarkers has opened new avenues for the multiplex assay market across North American nations.

Question 4: Which are the leading organizations in the multiplex assay market?

Answer: Siemens Healthineers AG, Seegene Inc, Merck Millipore, Bio Techne Corporation, Agilent Technologies Inc, Luminex Corporation, Randox Laboratories Ltd, Illumina Inc, Olink Proteomics AB, F Hoffmann La Roche, Abcam, Meso Scale Diagnostics LLC, Becton Dickinson and Company, Bio Rad Laboratories Inc, Qiagen NV, and Thermo Fisher Scientific Inc are leading organizations in the multiplex assay market.

Related Report:

Global Pharmaceutical Filtration Market
The global pharmaceutical filtration market is estimated to grow in its revenue during 2021-2028 at a CAGR of 8.56%. As a result, it is also likely to attain revenue worth $39947.0 million by 2028.

Pharmaceutical filters help produce small molecule elements, such as active pharmaceutical ingredients and excipients. Moreover, they are used in manufacturing various dosages of capsules, tablets, and more.

The market is witnessing growth mainly because of the rise in the manufacturing of large molecules and biologics, along with rising healthcare expenditure.

Additionally, the growing advancements in the biopharmaceutical industry are creating new opportunities for the pharmaceutical filtration market globally.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Multiplex Assay Market Assessed to Reap $7933.87 Million in Revenue by 2028 here

News-ID: 2374950 • Views: 238

More Releases from Triton Market Research

Global Cleanroom Swabs Market Estimated to Gain $443.88 Million in Revenue by 20 …
A recent study by Triton Market Research titled 'Global Cleanroom Swabs Market' entails the Global Analysis and Forecasts by End-user (Automotive, Food and Beverages, Defense and Aerospace, Medical, Electronics and Semiconductors, Pharmaceuticals, Others) and Geography (Europe, Middle East and Africa, Asia-Pacific, Latin America, North America,). Cleanroom swabs are designed for surface cleaning in small areas and offer cleaning validation. They are available in foam or fabric with a wide range
Global Cleanroom Consumables Market Estimated to Gain $22.92 Billion by 2028
A recent study by Triton Market Research titled Global Cleanroom Consumables Market entails the Global Analysis and Forecasts by End-user (Pharmaceuticals, Electronics & Semiconductor, Automotive, Defense & Aerospace, Medical, Food & Beverages, Other End-users), Product Type (Gloves, Face Shields/Face Masks, Cleanroom Packaging, Gown/Overalls & Aprons, Wipes, Footwear, Disinfectants & Cleaning Products, Hoods, Other Product Types), and by Geography (Middle East and Africa, Europe, Latin America, Asia-Pacific, and North America). Cleanroom
The Global Veterinary Vaccines Market to Reap $12119.03 Million by 2028
A recent study by Triton Market Research titled 'Global Veterinary Vaccines Market,' covers the Global Analysis and Forecasts by Product Type (Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines, Toxoid Vaccines, Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines), by Disease Type (Bovine Disease, Aquaculture Disease, Porcine Disease, Poultry Disease, Canine Disease, Other Disease Types), by Animal Type (Livestock Animals [Sheep, Cattle, Poultry, Pigs, Other Livestock Animals], Companion Animals [Equine, Feline, Canine], Aquaculture), and
Global Telecom API Market Estimated to Gain revenue at $615.99 Million by 2028
A recent study by Triton Market Research titled 'Global Telecom API Market' consists of the Global Analysis and Forecasts by End-user (Long-Tail Developer, Internal Telecom Developer, Partner Developer, Enterprise Developer), Deployment Mode (Multi-Cloud, Hybrid, Other Deployment Modes), Service (Subscriber Identity Management & SSO API, Location & Map API, IVR/ Voice Store & Voice Control API, Messaging API, Payment API, WebRTC API, Other Services), and by Geography (Middle East and Africa,

All 5 Releases


More Releases for Multiplex

Multiplex Assay Market Regulations and Competitive Landscape Outlook to 2027
An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay. The term multiplex refers to the highest number of analyte measurement per assay. Detection of the state of all biomolecules of a given class (i.e. proteins and mRNAs) within a
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assay Market : Opportunities, Demand and Forecasts, 2017 - 2027
An assay which simultaneously measures multiple analytes in a single cycle of the assay is known as a multiplex assay. Within a given application area of technology, multiplex assays can further stratify the analytes which are measured per assay. The term multiplex refers to the highest number of analyte measurement per assay. Detection of the state of all biomolecules of a given class (i.e. proteins and mRNAs) within a
Multiplex Assays Market - Niche Opportunities For Clients & Forecast 2017 - 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Assays Market Value Projected to Expand by 2025
Multiplex Assays Market: Snapshot The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027). Request for TOC @ https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc Increased spending on cancer diagnostic and monitoring Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising